B
BORSA.MCRO Research Dossier
Markets Terminal
Macro Group Pharmaceuticals -Macro Capital
MCROHealth Care & PharmaceuticalsISIN: EGS7D971C011

Macro Group Pharmaceuticals -Macro Capital

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال

1.74L.E
+3.57%+0.06 pts
Day Low: 1.67Day High: 1.76
EGX ClosedSource time: 2026-09-14 15:35
Previous Close
1.68
Open Price
1.68
Day High
1.76
Day Low
1.67
Turnover (EGP)
180.93M
Share Volume
104.71M
Trades Count
2,291
Market Cap
5.95B
Historical Price & Volume243 trading days

Period Return: -48.15%

2026-09-13

CLOSE1.68
VOLUME67.83M
TradingView Lightweight Charts™Daily Close & Volume points sourced from EGX

Financial Statement & Earnings Releases

Exact-ISIN matched results from EGX financial-statement and company-disclosure feeds.

EGX Financial Statements Source

Latest parsed result

Net profit · 01/01/2026 — 30/06/2026

consolidatedReviewed Comment : Taking into consideration minority rightsEGP

84.42M EGP

Comparative: 68.92M EGP

Profit +22.5% vs comparative period

Next reporting period

9M / Q3 2026 · period ends Sep 30, 2026

Company publication date: Not announced

Standard quarterly filing window: by Nov 14, 2026

Regulatory estimate only, based on the standard 45-day window and subject to FRA extensions. It is not a confirmed earnings date.

FRA filing rule
STRUCTURED EGX RESULT#293103consolidatedReviewed Comment : Taking into consideration minority rights

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 6 Months Consolidated Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها المجمعة عن 6 أشهر

Period: 01/01/2026 — 30/06/2026Published: 2026-08-13 15:20ISIN: EGS7D971C011
STRUCTURED EGX RESULT#293101standaloneReviewed

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 6 Months Standalone Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها غير المجمعة عن 6 أشهر

Period: 01/01/2026 — 30/06/2026Published: 2026-08-13 15:18ISIN: EGS7D971C011
STRUCTURED EGX RESULT#288348standaloneReviewed

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 3 Months Standalone Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها غير المجمعة عن 3 أشهر

Period: 01/01/2026 — 31/03/2026Published: 2026-05-17 14:49ISIN: EGS7D971C011
STRUCTURED EGX RESULT#288345consolidatedReviewed

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 3 Months Consolidated Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها المجمعة عن 3 أشهر

Period: 01/01/2026 — 31/03/2026Published: 2026-05-17 14:20ISIN: EGS7D971C011
STRUCTURED EGX RESULT#283787standaloneAudited

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports Year Ended 31/12/2025 Standalone Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها غير المجمعة عن السنة المالية المنتهية في 31/12/2025

Period: 01/01/2025 — 31/12/2025Published: 2026-02-19 10:58ISIN: EGS7D971C011
Statement 1 Statement 2

Showing 5 of 8 structured statements

Additional financial disclosures

Disclosure-derived records retained from the exact-ISIN company news feed. These are not labelled as structured earnings.

#293212GeneralFinancial Report2026-08-16 10:58

Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding the Company's Financial Results (in English)

بيان من ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) بخصوص نتائج أعمال الشركة (باللغة الانجليزية)

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Company's release regarding the company's financial results for the fiscal year ending on 30/06/2026 (in English). Release from the Company (1,105 KB)

Document
#288380GeneralFinancial Report2026-05-17 16:43

Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding the Company's Financial Results (in English)

بيان من ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) بخصوص نتائج أعمال الشركة باللغة الانجليزية

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Release from the company regarding the company's financial results in English for the period ending on 31/03/2026. Release from the Company (755 KB)

Document
#283841GeneralFinancial Report2026-02-23 10:16

Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding the Company's Financial Results (in English)

بيان من ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) بخصوص نتائج أعمال الشركة (باللغة الانجليزية)

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Release from the company regarding the company's financial results for the fiscal year ending 31/12/2025 (in English). Release from the Company in English (786 KB)

Document

Showing 3 of 3 sourced records

Official Corporate Disclosures

ISIN: EGS7D971C011

Official regulatory filings, corporate announcements, dividend pay dates, and board resolutions.

EGX News Source
#294040General2026-08-30 12:07

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) - Listing Committee Decision

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) - قرار لجنة القيد

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : The Listing Committee held on 26/08/2026 decided to address the company to abide by the provisions of Article 30 & 52 bis of the Listing Rules. Grant the company a period of 15 days to submit to the EGX the disclosure of the use of capital increase subscription proceeds and a report issued by the auditor or an independent financial advisor on the conformity of the actual uses to the disclosed uses.

#293212GeneralFinancial Report2026-08-16 10:58

Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding the Company's Financial Results (in English)

بيان من ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) بخصوص نتائج أعمال الشركة (باللغة الانجليزية)

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Company's release regarding the company's financial results for the fiscal year ending on 30/06/2026 (in English). Release from the Company (1,105 KB)

Document
#293106General2026-08-13 15:24

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) - Board of Directors Decisions

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) - قرارات مجلس إدارة الشركة

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Decisions of the company's Board of Directors at its meeting held on 12/08/2026. The BoD Decisions (1,173 KB)

Document
#293103Financial ResultsFinancial Report2026-08-13 15:20

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 6 Months Consolidated Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها المجمعة عن 6 أشهر

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Currency : EGP F/S Consolidated Period : From 01/01/2026 To 30/06/2026 Net Profit : 84,419,221 F/S Consolidated Period : From 01/01/2025 To 30/06/2025 Net Comparative Profit : 68,924,776 Audit Status : Reviewed Comment : Taking into consideration minority rights Source : Macro Group Pharmaceuticals -Macro Capital

#293101Financial ResultsFinancial Report2026-08-13 15:18

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 6 Months Standalone Results

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) تعلن نتائج اعمالها غير المجمعة عن 6 أشهر

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Currency : EGP F/S Standalone Period : From 01/01/2026 To 30/06/2026 Net Profit : 85,811,683 F/S Standalone Period : From 01/01/2025 To 30/06/2025 Net Comparative Profit : 71,283,081 Audit Status : Reviewed Source : Macro Group Pharmaceuticals -Macro Capital

#291453Shareholding Structure2026-07-16 10:23

Macro Group Pharmaceuticals - Macro Capital (MCRO.CA) - Disclosure Form for the BoD & the Shareholders' Structure

ماكرو جروب للمستحضرات الطبية - ماكرو كابيتال (MCRO.CA) - نموذج تقرير إفصاح عن مجلس الإدارة وهيكل المساهمين

Company: Macro Group Pharmaceuticals - Macro Capital Symbols: EGS7D971C011 Reuters: MCRO.CA Content : The company sent its disclosure form for the Board of Directors and the shareholders' structure for the period on 30/06/2026, according to Article 30 of the Listing Rules. The Disclosure Form (4,827 KB)

Document
#291010General2026-07-08 11:27

Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding a Disclosure Form

بيان من ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) بخصوص نموذج إفصاح

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : Release from the company regarding the disclosure form for the use of proceeds from the capital increase subscription for the financial period ending on 31/03/2026. Release from the Company (1,740 KB)

Document
#289756General2026-06-11 15:28

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) - Listing Committee Decision

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال (MCRO.CA) - قرار لجنة القيد

Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : The Listing Committee held 10/06/2026 decided to warn the company to abide by the provisions of Article 31 of the Listing Rules and Article 45 of the executive regulations.

Showing 8 of 50 sourced records

Public EGX website snapshot. Production live redistribution requires licensing and permission from EGX / EGID.

EGX Website Source
Official Register

Company Facts & Ratios

Source

ماكرو جروب للمستحضرات الطبية-ماكرو كابيتال

Latest earnings

Period ended Jun 30, 2026

EGX

84.42M EGP

Net profit+22.5% vs comparative periodconsolidated
Next reporting period

9M / Q3 2026 · ends Sep 30, 2026

Estimated FRA filing window: by Nov 14, 2026

ISIN Code
EGS7D971C011
Sector
Health Care & Pharmaceuticals
Listing Date
2022-01-12
Listed Shares
3,421,238,736
Par Value
0.2 EGP
P/E Ratio
49.63
Dividend Yield
0%
Coupon Count
2
Latest Coupon
0.11 EGP
Coupon Pay Date
2023-04-20
Trading Schedule
Egyptian securities-Stocks
Reported Index Memberships
EGX70EGX100
Regulatory Flags
IntradayTRUE
FACTUAL DATA COMPUTATION — NOT INVESTMENT ADVICE

Automated Market Liquidity & Price Note

  • Session DeltaThe snapshot is 0.06 L.E above the reported previous close. (Formula: current price − previous close).
  • Historical WindowAcross the available 705 trading days, the total close-to-close change is -34.38%.
  • Session LiquidityThe current snapshot reports 180.93M L.E turnover across 2,291 trades and 104.71M shares.